Abstract
American cutaneous leishmaniasis (ACL), an infectious disease, not contagious, of vectorial transmission with heteroxenic cycle, which affects the skin and mucous membranes. The drugs currently available for treatment of the disease are poor due to their limited efficacy and side effects, besides the high cost and the resistance against protozoa accumulate these drugs. Lipid formulations …